Search results
Lack of insurance may prevent Americans from accessing best cancer drugs
United Press International via Yahoo News· 20 hours agoA cutting-edge class of drugs is saving and extending the lives of cancer patients. But the drugs,...
Pfizer sees lung cancer drug topping $1 billion in sales following impressive 5-year data
FOX Business· 4 days agoPfizer said it expects its cancer drug Lorbrena to top $1 billion in annual sales by 2030 on the...
Bristol’s $250,000 Pill Slows Lung Cancer Growth by Seven Weeks
Bloomberg· 3 days agoHave a confidential tip for our reporters? A Bristol Myers Squibb Co. lung cancer treatment delayed ...
Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors...
KOLR - KSFX Ozarks· 3 days agoOlomorasib is an investigational, oral, potent, and highly selective second-generation inhibitor of the KRAS G12C protein.
Six cancer treatment breakthroughs pushing us closer to a cure
The Telegraph via Yahoo News· 4 days agocancer vaccine trial sponsored by BioNTech SE. In July last year, the Government signed an agreement...
GRIT and Quangang announce IL-2 T-cell therapy partnership
Pharmaceutical Technology via Yahoo Finance· 1 day agoQuanqi (125SER) is a marketed human Interleukin-2 used in treating solid tumours including renal...
Gilead’s Trodelvy extends lung cancer survival by just 1.3 months in trial
WHTC 1450 Holland· 4 days agoBy Deena Beasley (Reuters) - Gilead Sciences' Trodelvy improved survival by 1.3 months more than...
Truist Securities ups Genmab shares target By Investing.com
Investing.com· 35 minutes agoTuesday, on Wall Street, Genmab A/S (NASDAQ:GMAB) received a positive assessment from Truist...
Summit Therapeutics sees stock soar 272% after lung cancer clinical trial - Silicon Valley Business...
The Business Journals· 4 days agoInc. investors sent the company's stock up 272% Thursday following the release of an early read of...
Gilead's Trodelvy fails bladder cancer trial, modestly extends lung cancer survival
Reuters· 4 days ago, opens new tab Trodelvy failed to improve survival for patients with advanced bladder cancer and...